NorthShore University Health System
Evanston, Illinois, 60201, United States
NCT Number: NCT04774471
The purpose of this research is to evaluate the accuracy of the BIT-Motion (Breast Imaging Tensor-Motion) software with non-contrast MRI scanning to detect breast cancer.
Looking for future studies?
Notify Me18 year and older
Female
Observational
Evanston, Illinois, 60201, United States
The goal of this study is to answer the question: what is the ability of the BIT-Motion (Breast Imaging Tensor-Motion) software to detect and discriminate between benign and malignant breast lesions that are identified on mammogram (MG) and ultrasound (US) examinations. Women over the age of 18 who have a breast lesion that is seen on MG or US will be eligible to enroll. Participation in this study will involve one non-invasive non-contrast MRI scan of the breasts.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Software program to discern benign versus malignant breast lesions.
Time frame: One month
MRI scans evaluated with BIT-Motion software will be compared to definitive pathologic diagnosis
Endeavor Health
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04341129
Adenocarcinoma, Breast Cancer
Chicago, Illinois, United States
View Trial DetailsNCT03868514
Breast Cancer, Breast Diseases
Vienna, Austria
View Trial DetailsNCT05232084
Breast Cancer, Breast Diseases
Istanbul, Bagcilar, Turkey (Türkiye)
View Trial DetailsNCT05327218
Breast Cancer, Breast Diseases
Paris, France
View Trial Details